Labiofam manufactures and sales antibacterial lotion

With great acceptance and demand, it has started the sale in the province of an antibacterial and disinfectant lotion produced here.

Las Tunas, Cuba.- Patented by the Biopharmaceutical Medical Laboratories Company (Labiofam) Las Tunas, it is intended for hand disinfection, as part of the preventive work against COVID-19.

The product, totally new in the entity, is manufactured in the Plant for production of biopreparations, located in Río Potrero; and according to reports by Lisbet Almaguer Batista, director of the Production and Marketing base business unit, the lotion is made up of alcohol at 75 percent, preservative essence and propoline, in moderate proportion for disinfection.

Antibacterial disinfectant lotionManufacturing on the first day was 1,500 bottles, while on the second day they totaled more than 2,000, distributed in the markets El Tunero and El Mambí; at the point of sale near the Tres Casitas childcare center and at La Esquina, located on the Martí Street, all in this city. In addition, other marketing sites are planned so that the product reaches as many people as possible.

Regarding the sustainability of the product in the marketing network, the directive assured that "at the moment we have the base raw material for the lotion, alcohol, since we have a strengthened relationship with the Tecnoazúcar Company, our provider. For this first stage, we have bought more than 10,000 liters of the antiseptic liquid, and the rest of the components are already guaranteed to provide thousands of more knobs."

With a presentation of 500 milliliters, at the price of 10.00 pesos in national currency, the population can purchase the bottle, which has an exquisite fragrance that perfumes the hands, while sanitizing them.

The idea arose as a result of the situation our country is experiencing today with the new coronavirus, explains Almaguer Batista. Preceded only by the Sancti Spíritus Company, Labiofam Las Tunas presents the bactericide as a vital alternative to be protected against the SARS-CoV-2 virus, the cause of the disease that is currently mourning the world.

Currently, they are directly selling it to the population in the capital city, later it will be taken to the other municipalities and it can also be marketed with state companies through a contract with this biopharmaceutical entity.